Search

Search Constraints

You searched for: Author/Creator Packer, M

Search Results

3. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022)

4. Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: insights from PARADIGM-HF. (3rd October 2022)

5. Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials. (3rd October 2022)

7. Stroke in patients with heart failure and reduced ejection fraction without atrial fibrillation: external validation of a risk model. (3rd October 2022)

10. History of stroke in patients with heart failure: prevalence, baseline characteristics and clinical outcomes. (3rd October 2022)